That is, ZEB1 levels increased in cancer tissues without metastasis compared with normal tissues, and they further increased in localised BRCA tissues with distant metastasis, contrary to the SLFN5 expression pattern in BRCA (Fig. 4q, luminal A and triple negative; Supplementary Fig. S5, luminal B and HER2+). This evidence concerns the gene ERBB2 and cancer.